Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles. | J Extracell Vesicles | 2022 | 35411723 | PubTator, text mining | PubMed |
| Cell pyroptosis in health and inflammatory diseases. | Cell Death Discov | 2022 | 35411030 | PubTator, text mining | PubMed |
| Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation? | Int J Mol Sci | 2022 | 35408940 | PubTator, text mining | PubMed |
| Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration. | Front Aging Neurosci | 2022 | 35401152 | PubTator, text mining | PubMed |
| Cholesterol metabolism and its implication in glioblastoma therapy. | J Cancer | 2022 | 35399707 | PubTator, text mining | PubMed |
| Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions. | Front Genet | 2022 | 35391801 | PubTator, text mining | PubMed |
| 2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis. | Arterioscler Thromb Vasc Biol | 2022 | 35387480 | PubTator, text mining | PubMed |
| Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway. | Sci Rep | 2022 | 35379885 | PubTator, text mining | PubMed |
| Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus. | Front Immunol | 2022 | 35371016 | PubTator, text mining | PubMed |
| Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents. | Front Med (Lausanne) | 2022 | 35360730 | PubTator, text mining | PubMed |
| Identification of potential modifier genes in Chinese patients with Wilson disease. | Metallomics | 2022 | 35357466 | PubTator, text mining | PubMed |
| Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies. | J Tissue Eng | 2022 | 35356091 | PubTator, text mining | PubMed |
| The functional insight into the genetics of cardiovascular disease: results from the post-GWAS study. | Vavilovskii Zhurnal Genet Selektsii | 2022 | 35342858 | PubTator, text mining | PubMed |
| Pseudorabies Virus Inhibits Expression of Liver X Receptors to Assist Viral Infection. | Viruses | 2022 | 35336921 | PubTator, text mining | PubMed |
| Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor. | Sci Adv | 2022 | 35333579 | PubTator, text mining | PubMed |
| Coronary Malperfusion Secondary to Acute Type A Aortic Dissection: Surgical Management Based on a Modified Neri Classification. | J Clin Med | 2022 | 35330018 | PubTator, text mining | PubMed |
| Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery. | Int J Mol Sci | 2022 | 35328759 | PubTator, text mining | PubMed |
| Polyunsaturated Fatty Acid-Enriched Lipid Fingerprint of Glioblastoma Proliferative Regions Is Differentially Regulated According to Glioblastoma Molecular Subtype. | Int J Mol Sci | 2022 | 35328369 | PubTator, text mining | PubMed |
| Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH. | Metabolites | 2022 | 35323681 | PubTator, text mining | PubMed |
| Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease. | J Alzheimers Dis | 2022 | 35311709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=20